Firazyr (Shire US Manufacturing Inc.)
Welcome to the PulseAid listing for the Firazyr drug offered from Shire US Manufacturing Inc.. This Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Shire US Manufacturing Inc. |
NON-PROPRIETARY NAME: | icatibant acetate |
SUBSTANCE NAME: | ICATIBANT ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-08-25 |
END MARKETING DATE: | 0000-00-00 |
Firazyr HUMAN PRESCRIPTION DRUG Details:
Item Description | Firazyr from Shire US Manufacturing Inc. |
LABELER NAME: | Shire US Manufacturing Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/3mL) |
START MARKETING DATE: | 2011-08-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54092-702_1e84d420-d06d-4eaf-954d-91d44232c500 |
PRODUCT NDC: | 54092-702 |
APPLICATION NUMBER: | NDA022150 |
Other ICATIBANT ACETATE Pharmaceutical Manufacturers / Labelers: